Suchen





Suchen





Märkte
/
Aktien
/
nasdaq-tech
/

Bio-Techne Corp

TECH

Zur Watchlist hinzufügen

44.900USD

-2.520-5.31%

Handelsschluss 05/13, 16:00（ET）Kurse um 15 Minuten verzögert

7.03BMarktkapitalisierung

63.62KGV TTM



Bio-Techne Corp

44.900

-2.520-5.31%

Übersicht Finanzen Diskussionen Analyse Unternehmen

Übersicht

Finanzen

Diskussionen

Analyse

Unternehmen

mehr Informationen über Bio-Techne Corp Unternehmen

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Bio-Techne Corp Informationen



BörsenkürzelTECH

Name des UnternehmensBio-Techne Corp

IPO-datumFeb 09, 1989

CEOKelderman (Kim)

Anzahl der mitarbeiter3100

WertpapierartOrdinary Share

GeschäftsjahresendeFeb 09

Addresse614 Mckinley Pl N E

StadtMINNEAPOLIS

BörseNASDAQ OMX - NASDAQ BASIC

LandUnited States of America

Postleitzahl55413

Telefon16123798854

Websitehttps://www.bio-techne.com/

BörsenkürzelTECH

IPO-datumFeb 09, 1989

CEOKelderman (Kim)

Führungskräfte von Bio-Techne Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. John L. Higgins

Independent Director

66.88K

+2.45%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

63.06K

+22.83%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+3.53%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+10.64%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+14.93%

Ms. Julie L. Bushman

Independent Director

8.78K

+18.69%

Mr. Shane Bohnen

Senior Vice President, General Counsel, Corporate Secretary

5.90K

+25.73%

Dr. Judith V. Klimovsky, M.D.

Independent Director

3.78K

+43.36%

Mr. James T. (Jim) Hippel

Chief Financial Officer, Executive Vice President - Finance

Mr. David Clair

Investor Relations

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. John L. Higgins

Independent Director

66.88K

+2.45%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

63.06K

+22.83%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+3.53%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+10.64%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+14.93%

Ms. Julie L. Bushman

Independent Director

8.78K

+18.69%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6

FY2026Q2

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Consumables

235.44M

79.57%

Instruments

29.61M

10.01%

Service

22.32M

7.54%

Royalty

8.51M

2.88%

Nach RegionUSD

Name

Umsatz

Anteil

United States

146.56M

49.53%

EMEA, excluding U.K

75.35M

25.47%

Greater China

26.35M

8.91%

APAC, excluding Greater China

22.74M

7.69%

United Kingdom

13.73M

4.64%

Rest of World

11.14M

3.77%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Consumables

235.44M

79.57%

Instruments

29.61M

10.01%

Service

22.32M

7.54%

Royalty

8.51M

2.88%

Aktionärsstatistik

Aktualisiert: Mon, May 11

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Vanguard Capital Management, LLC

6.50%

BlackRock Institutional Trust Company, N.A.

5.84%

Vanguard Portfolio Management, LLC

4.14%

State Street Investment Management (US)

3.71%

Wellington Management Company, LLP

3.66%

Andere

76.15%

Aktionäre

Anteil

Vanguard Capital Management, LLC

6.50%

BlackRock Institutional Trust Company, N.A.

5.84%

Vanguard Portfolio Management, LLC

4.14%

State Street Investment Management (US)

3.71%

Wellington Management Company, LLP

3.66%

Andere

76.15%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

60.05%

Investment Advisor/Hedge Fund

37.12%

Hedge Fund

9.13%

Research Firm

2.58%

Bank and Trust

1.97%

Pension Fund

1.77%

Sovereign Wealth Fund

1.08%

Individual Investor

0.30%

Insurance Company

0.23%

Institutionelle Beteiligung



Aktualisiert: Sun, Apr 5

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2026Q1

1247

178.19M

113.81%

+1.43K

2025Q4

1230

172.60M

110.32%

+3.07M

2025Q3

1198

161.18M

103.53%

-7.34M

2025Q2

1209

165.25M

105.41%

-730.33K

2025Q1

1245

168.10M

107.22%

+1.54M

2024Q4

1233

162.21M

102.61%

-6.39M

2024Q3

1205

159.40M

100.49%

-10.21M

2024Q2

1207

160.52M

101.86%

-12.24M

2024Q1

1216

162.56M

103.40%

-7.57M

2023Q4

1229

159.70M

100.98%

-3.97M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

9.14M

5.84%

+350.80K

+3.99%

Dec 31, 2025

State Street Investment Management (US)

5.81M

3.71%

+58.64K

+1.02%

Dec 31, 2025

Wellington Management Company, LLP

5.73M

3.67%

+618.92K

+12.10%

Dec 31, 2025

Geode Capital Management, L.L.C.

4.93M

3.15%

+2.62K

+0.05%

Dec 31, 2025

Atlanta Capital Management Company, L.L.C.

4.83M

3.08%

-115.50K

-2.34%

Dec 31, 2025

MFS Investment Management

3.91M

2.5%

+2.46M

+169.79%

Dec 31, 2025

Maverick Capital, Ltd.

3.85M

2.46%

+838.27K

+27.82%

Dec 31, 2025

T. Rowe Price Associates, Inc.

3.85M

2.46%

+725.05K

+23.23%

Dec 31, 2025

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

Global X Genomics & Biotechnology ETF

4.29%

Invesco Biotechnology & Genome ETF

2.92%

Invesco S&P 500 Equal Weight Health Care ETF

Neuberger Berman Small-Mid Cap ETF

1.78%

VanEck Biotech ETF

1.73%

Hilton Small-MidCap Opportunity ETF

1.7%

iShares Health Innovation Active ETF

1.68%

American Century Mid Cap Growth Impact ETF

1.47%

Thrivent Small-Mid Cap ESG ETF

1.34%

Invesco S&P 500 High Beta ETF

1.06%

Global X Genomics & Biotechnology ETF

Anteil4.29%

Invesco Biotechnology & Genome ETF

Anteil2.92%

Invesco S&P 500 Equal Weight Health Care ETF

Anteil2%

Neuberger Berman Small-Mid Cap ETF

Anteil1.78%

VanEck Biotech ETF

Anteil1.73%

Hilton Small-MidCap Opportunity ETF

Anteil1.7%

iShares Health Innovation Active ETF

Anteil1.68%

American Century Mid Cap Growth Impact ETF

Anteil1.47%

Thrivent Small-Mid Cap ESG ETF

Anteil1.34%

Invesco S&P 500 High Beta ETF

Anteil1.06%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 250.90M USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

May 06, 2026

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 29, 2026 going ex on May 18, 2026

May 18, 2026

May 29, 2026

May 18, 2026

Feb 04, 2026

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 27, 2026 going ex on Feb 13, 2026

Feb 16, 2026

Feb 27, 2026

Feb 13, 2026

Nov 05, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 28, 2025 going ex on Nov 17, 2025

Nov 17, 2025

Nov 28, 2025

Nov 17, 2025

Aug 06, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 29, 2025 going ex on Aug 18, 2025

Aug 18, 2025

Aug 29, 2025

Aug 18, 2025

May 07, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 30, 2025 going ex on May 19, 2025

May 19, 2025

May 30, 2025

May 19, 2025

Feb 05, 2025

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 17, 2025

Feb 28, 2025

Feb 14, 2025

Oct 30, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024

Nov 11, 2024

Nov 22, 2024

Nov 08, 2024

Aug 07, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024

Aug 19, 2024

Aug 30, 2024

Aug 19, 2024

May 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024

May 13, 2024

May 24, 2024

May 10, 2024

Feb 01, 2024

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024

Feb 12, 2024

Feb 26, 2024

Feb 09, 2024

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Nov 01, 2022

Split

1→4

Datum

Ex-Dividendentag

Art

Verhältnis

Nov 01, 2022

Split

1→4

KeyAI

